Company Search:
Advanced Search
Sponsored Links
Stada Arzneimittel AG Company Snapshot
Stada Arzneimittel AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Stada Arzneimittel AG with three other pharmaceutical manufacturers in Europe: Ipsen SA of France (2017 sales of 2.01 billion Euro [US$2.49 billion] of which 79% was Specialty Care), Hikma Pharmaceuticals PLC of the United Kingdom (£1.49 billion [US$2.11 billion] of which 40% was Injectable Pharmaceuticals), and H. Lundbeck A/S which is based in Denmark (17.23 billion Danish Kroner [US$2.86 billion] of which 18% was Onfi).

Sales Analysis. Stada Arzneimittel AG reported sales of 2.31 billion Euro (US$2.86 billion) for the year ending December of 2017. This represents an increase of 8.2% versus 2016, when the company's sales were 2.14 billion Euro. Sales at Stada Arzneimittel AG have increased during each of the previous five years (and since 2012, sales have increased a total of 26%). Sales of Branded Products saw an increase of 10.9% in 2017, from 858.46 million Euro to 952.25 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Stada Arzneimittel AG
  Stock Performance Chart for Stada Arzneimittel AG
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 84.00
(Figures in Euro)
1 Week -0.1%   13 Weeks 0.1%  
4 Weeks -5.5%   52 Weeks 30.3%  
Stada Arzneimittel AG Key Data:
  Ticker: SAZ Country: Germany
  Exchanges: FRA OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,313,928,000
(Year Ending Jan 2018).
Employees: 10,176
  Currency: Euro Market Cap: 5,229,682,836
  Fiscal Yr Ends: December Shares Outstanding: 62,258,129
  Share Type: Namensaktie Closely Held Shares: 40,207,975
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.